Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q8N5I4
UPID:
DHRSX_HUMAN
Alternative names:
DHRSXY; Short chain dehydrogenase/reductase family 46C member 1; Short chain dehydrogenase/reductase family 7C member 6
Alternative UPACC:
Q8N5I4; Q6UWC7; Q8WUS4; Q96GR8; Q9NTF6
Background:
Dehydrogenase/reductase SDR family member on chromosome X, also known as DHRSXY, plays a crucial role in the positive regulation of starvation-induced autophagy. This protein, with alternative names such as Short chain dehydrogenase/reductase family 46C member 1 and Short chain dehydrogenase/reductase family 7C member 6, is pivotal in cellular processes.
Therapeutic significance:
Understanding the role of Dehydrogenase/reductase SDR family member on chromosome X could open doors to potential therapeutic strategies. Its involvement in autophagy regulation suggests its potential in targeting diseases where autophagy plays a critical role.